Articles

Articles 5,464 registres trobats  inicianterior433 - 442següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
433.
9 p, 1013.2 KB Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis : a post hoc pooled analysis of AMAGINE-2 and -3 / Reich, K. (University Medical Center Hamburg-Eppendorf) ; Iversen, L. (Aarhus University Hospital (Aarhus, Dinamarca)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Lambert, Jo (Ghent University) ; Mrowietz, Ulrich (University Medical Center Schleswig-Holstein) ; Kaplan Saday, K. (LEO Pharma A/S) ; Warren, R. B. (University of Manchester) ; Universitat Autònoma de Barcelona
Brodalumab is a monoclonal antibody that blocks multiple interleukin (IL)-17 family cytokines by binding to the shared A subunit of the IL-17 receptor. In Phase 3 trials, brodalumab provided high levels of skin clearance through 52 weeks in patients with moderate-to-severe psoriasis and was generally well tolerated. [...]
2022 - 10.1111/jdv.18068
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 8 (august 2022) , p. 1275-1283  
434.
11 p, 1.4 MB A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation map / Pottie, Kevin (Western University) ; Smith, Maureen (Cochrane Consumer Network Executive) ; Matthews, Micayla (McMaster University) ; Santesso, Nancy (McMaster University) ; Magwood, Olivia (University of Ottawa) ; Kredo, Tamara (Stellenbosch University) ; Scott, Sarah (McMaster University) ; Bayliss, Kerin (National Institute for Health and Care Excellence) ; Saad, Ammar (University of Ottawa) ; Haridas, Rinila (University of Ottawa) ; Detambel, Nicole (McMaster University) ; Motilall, Ashley (McMaster University) ; Tan, Yvonne (University of Ottawa) ; Steinberg, Sally (Lancaster High School) ; Litynska, Justyna (Evidence Prime. Inc.) ; Dietl, Bart (Evidence Prime. Inc.) ; Iorio, Alfonso (McMaster University) ; Reveiz, Ludovic (Pan American Health Organization) ; Welch, Vivian (University of Ottawa) ; Klugar, Miloslav (Czech National Centre for Evidence-Based Healthcare and Knowledge Translation Brno) ; Mbuagbaw, Lawrence (Cochrane South Africa) ; Rojas-Reyes, Maria Ximena (Institut d'Investigació Biomèdica Sant Pau) ; Florez, Ivan D (Clinica Las Americas-AUNA) ; Lotfi, Tamara (McMaster University) ; Qaseem, Amir (American College of Physicians) ; Mathew, Joseph L. (Postgraduate Institute of Medical Education and Research) ; Akl, Elie A (American University of Beirut) ; Tugwell, Peter (University of Ottawa) ; Schünemann, Holger J. (McMaster University) ; Universitat Autònoma de Barcelona
To develop a digital communication tool to improve the implementation of up-to-date COVID-19 recommendations. Specifically, to improve patient, caregiver and public understanding of healthcare recommendations on prevention, diagnoses and treatment. [...]
2022 - 10.1016/j.jclinepi.2022.04.012
Journal of Clinical Epidemiology, Vol. 148 (august 2022) , p. 104-114  
435.
9 p, 751.0 KB Role of Pediatric Ureteral Access Sheath and Outcomes Related to Flexible Ureteroscopy and Laser Stone Fragmentation : A Systematic Review of Literature / Ripa, Francesco (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Tokas, Theodoros (Training and Research in Urological Surgery and Technology (T.R.U.S.T.) Group) ; Griffin, Stephen (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Ferretti, Stefania (Hospital and University of Parma) ; Bujons Tur, Anna (Institut d'Investigació Biomèdica Sant Pau) ; Somani, Bhaskar K. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Universitat Autònoma de Barcelona
Flexible ureteroscopy and laser lithotripsy (FURSL) represent a good treatment option for pediatric urolithiasis. Scarce evidence is available about the safety and efficacy of the concomitant use of a ureteral access sheath (UAS) in the setting of pediatric ureteroscopy (URS). [...]
2022 - 10.1016/j.euros.2022.09.012
European Urology Open Science, Vol. 45 (november 2022) , p. 90-98  
436.
6 p, 420.6 KB Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model / Queiro, Rubén (Universidad de Oviedo) ; Seoane-Mato, Daniel (Sociedad Española de Reumatologia) ; Laiz, Ana (Institut d'Investigació Biomèdica Sant Pau) ; Agirregoikoa, Eva Galíndez (Hospital Universitario Basurto) ; Montilla, Carlos (Hospital Universitario de Salamanca) ; Park, Hye-Sang (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Pinto-Tasende, Jose A. (Complexo Hospitalario Universitario de A Coruña) ; Bethencourt Baute, Juan José (Hospital Universitario de Canarias (La Laguna)) ; Ibáñez, Beatriz Joven (Hospital Universitario 12 de Octubre) ; Toniolo, Elide (Hospital Universitari Son Llàtzer) ; Ramírez, Julio (Hospital Clínic i Provincial de Barcelona) ; García, Ana Serrano (Universidad Autónoma de Madrid) ; Cañete, Juan D. (Hospital Clínic i Provincial de Barcelona) ; Juanola, Xavier (Hospital Universitari de Bellvitge) ; Gratacós, Jordi (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Rodriguez-Moreno, Jesús (Hospital Universitari de Bellvitge) ; Notario Rosa, Jaime (Hospital Universitari de Bellvitge) ; López-Ferrer, Anna (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Cuervo, Andrea (Hospital Clínic i Provincial de Barcelona) ; Alsina Gibert, Mercè (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
To evaluate which patient and disease characteristics are associated with the perception of high-impact disease (PsAID ≥4) in recent-onset psoriatic arthritis. We performed a multicenter observational prospective study (2-year follow-up, regular annual visits). [...]
2022 - 10.1016/j.semarthrit.2022.152097
Seminars in Arthritis and Rheumatism, Vol. 57 (december 2022) , p. 152097  
437.
10 p, 1.8 MB Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis / Reich, Kristian (University Medical Center Hamburg-Eppendorf) ; Conrad, Curdin (University Hospital Lausanne CHUV) ; Kristensen, Lars Erik (Lund University) ; Smith, Saxon D. (The University of Sydney) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Rich, Phoebe (Oregon Dermatology and Research Center) ; Sapin, Christophe (Eli Lilly and Company) ; Holzkaemper, Thorsten (Eli Lilly and Company) ; Koppelhus, Uffe (Eli Lilly and Company) ; Schuster, Christopher (Medical University of Vienna) ; Universitat Autònoma de Barcelona
Nail psoriasis (NP) is common and of high importance in patients with psoriasis. Complete resolution of NP at week 24‒26 is an unambiguous nail outcome accessible for indirect treatment comparison of biologics. [...]
2022 - 10.1080/09546634.2021.1892024
Journal of Dermatological Treatment, Vol. 33 Núm. 3 (2022) , p. 1652-1660  
438.
12 p, 468.2 KB In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida : A European Study / Quindós, Guillermo (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Miranda-Cadena, Katherine (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; San-Millán, Rosario (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Borroto-Esoda, Katyna ; Cantón, Emilia (Hospital Universitario y Politécnico La Fe) ; Linares-Sicilia, María José (Universidad de Córdoba) ; Hamprecht, Axel (University of Oldenburg) ; Montesinos, Isabel (Hospital Universitario Basurto BioCruces Bizkaia) ; Tortorano, Anna Maria (Università degli Studi di Milano) ; Prigitano, Anna (Università degli Studi di Milano) ; Vidal-García, Matxalen (Hospital Universitario Basurto BioCruces Bizkaia) ; Marcos-Arias, Cristina (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Guridi, Andrea (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Sanchez-Reus, Ferran (Institut d'Investigació Biomèdica Sant Pau) ; Machuca-Bárcena, Jesús (Universidad de Cádiz) ; Rodríguez-Iglesias, Manuel Antonio (Universidad de Cádiz) ; Martín-Mazuelos, Estrella (Hospital Universitario de Valme) ; Castro-Méndez, Carmen (Hospital Universitario de Valme) ; López-Soria, Leyre (Hospital Universitario de Cruces and BioCruces Bizkaia) ; Ruiz-Gaitán, Alba (Instituto de Investigación Sanitaria. Hospital Universitario y Politécnico La Fe) ; Fernandez-Rivero, Marcelo (Hospital Universitario y Politécnico La Fe) ; Lorenzo, Damaris (Universitat Rovira i Virgili) ; Capilla, Javier (Universitat Rovira i Virgili) ; Rezusta, Antonio ; Pemán, Javier (Hospital Universitario y Politécnico La Fe) ; Guarro, Josep (Universitat Rovira i Virgili) ; Pereira, Joana (University of Minho) ; Pais, Célia (University of Minho) ; Romeo, Orazio (University of Messina) ; Ezpeleta, Guillermo (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Jauregizar, Nerea (Universidad del País Vasco) ; Angulo, David ; Eraso, Elena (Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU)) ; Universitat Autònoma de Barcelona
Ibrexafungerp (SCY-078) is the newest oral and intravenous antifungal drug with broad activity, currently undergoing clinical trials for invasive candidiasis. The aim of this study was to assess the in vitro activity of ibrexafungerp and comparators against a collection of 434 European blood isolates of Candida. [...]
2022 - 10.3389/fcimb.2022.906563
Frontiers in cellular and infection microbiology, Vol. 12 (16 2022) , p. 906563  
439.
11 p, 265.1 KB Safinamide in clinical practice : A Spanish multicenter cohort study / Martí-Andrés, Gloria (Clínica Universidad de Navarra) ; Jiménez-Bolaños, Rayco (Hospital Universitario Insular de Gran Canaria) ; Arbelo-González, José Matias (Hospital Universitario Insular de Gran Canaria) ; Pagonabarraga Mora, Javier (Institut d'Investigació Biomèdica Sant Pau) ; Duran-Herrera, Carmen (Hospital Universitario de Badajoz) ; Valenti-Azcarate, Rafael (Clínica Universidad de Navarra) ; Luquin, Mª Rosario (Clínica Universidad de Navarra) ; Universitat Autònoma de Barcelona
Safinamide is an approved drug for the treatment of motor fluctuations of Parkinson's Disease (PD) patients with a potential benefit on non-motor symptoms (NMS). A retrospective multicenter cohort study was conducted, in which the clinical effect of safinamide on both motor and NMS was assessed by the Clinical Global Impression of Change scale. [...]
2019 - 10.3390/brainsci9100272
Brain sciences, Vol. 9 Núm. 10 (october 2019) , p. 272  
440.
8 p, 594.7 KB The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes : Achieving HbA1c targets with basal insulin in a real-world setting / Meneghini, Luigi F. (Parkland Health & Hospital System) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Orsi, Emanuela (Fondazione Ca' Granda IRCCS) ; Lalic, Nebojsa M. (University of Belgrade) ; Cali, Anna M.G. (Sanofi) ; Westerbacka, Jukka (Sanofi) ; Stella, Peter (Sanofi) ; Candelas, Christophe (Sanofi) ; Pilorget, Valerie (Sanofi) ; Perfetti, Riccardo (Sanofi) ; Khunti, Kamlesh (University of Leicester) ; Universitat Autònoma de Barcelona
To describe in a real-world setting the achievement of physician-selected individualized HbA1c targets in individuals with type 2 diabetes, newly or recently initiated with basal insulin, and the association of hypoglycaemia with target achievement. [...]
2019 - 10.1111/dom.13673
Diabetes, Obesity and Metabolism, Vol. 21 Núm. 6 (june 2019) , p. 1429-1436  
441.
9 p, 1012.4 KB Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity : A cross-sectional analysis from the AB255 Study / Pérez-Grijalba, Virginia (Araclon Biotech S.L.) ; Arbizu, Javier (Clínica Universidad de Navarra) ; Romero, Judith (Araclon Biotech S.L.) ; Prieto, Elena (Clínica Universidad de Navarra) ; Pesini, Pedro (Araclon Biotech S.L.) ; Sarasa, Leticia (Araclon Biotech S.L.) ; Guillen, Fernando (Clínica Universidad de Navarra) ; Monleón, Inmaculada (Araclon Biotech S.L.) ; San-José, Itziar (Araclon Biotech S.L.) ; Martínez-Lage, Pablo (Fundación CITA-Alzheimer) ; Munuera, Josep (Institut de Recerca Sant Joan de Déu) ; Hernández, Isabel (Instituto de Salud Carlos III) ; Buendía, Mar (Universitat Internacional de Catalunya) ; Sotolongo-Grau, Oscar (Universitat Internacional de Catalunya) ; Alegret, Montserrat (Instituto de Salud Carlos III) ; Ruiz, Agustín (Instituto de Salud Carlos III) ; Tárraga, Lluís (Instituto de Salud Carlos III) ; Boada, Mercè (Instituto de Salud Carlos III) ; Sarasa, Manuel (Araclon Biotech S.L.) ; Goñi Imízcoz, Miguel (Hospital Divino Vallés (Burgos)) ; Pujadas, Francesc ; Villarejo, Alberto ; Frank, Ana ; Peña-Casanova, Jordi ; Fernández, Manuel ; Piñol, Gerard ; Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ; Gil, Pedro ; Pascual, Luis F. ; Aguilar Barberà, Miquel ; Frisoni, Giovanni B. ; Matias-Guiu, Jorge ; Andreasen, Niels ; Antúnez, Carmen ; Universitat Autònoma de Barcelona
To facilitate population screening and clinical trials of disease-modifying therapies for Alzheimer's disease, supportive biomarker information is necessary. This study was aimed to investigate the association of plasma amyloid-beta (Aβ) levels with the presence of pathological accumulation of Aβ in the brain measured by amyloid-PET. [...]
2019 - 10.1186/s13195-019-0549-1
Alzheimer's research & therapy, Vol. 11 Núm. 1 (january 2019) , p. 96  
442.
12 p, 2.4 MB Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers / Page, Elizabeth C. (Institute of Cancer Research) ; Bancroft, Elizabeth K. (Royal Marsden NHS Foundation Trust) ; Brook, Mark N. (Institute of Cancer Research) ; Assel, Melissa (Memorial Sloan Kettering Cancer Center) ; Hassan Al Battat, Mona (Lund University) ; Thomas, Sarah (Royal Marsden NHS Foundation Trust) ; Taylor, Natalie (Royal Marsden NHS Foundation Trust) ; Chamberlain, Anthony (Institute of Cancer Research) ; Pope, Jennifer (Institute of Cancer Research) ; Raghallaigh, Holly Ni (Institute of Cancer Research) ; Evans, D.Gareth (Central Manchester University Hospitals NHS Foundation Trust) ; Rothwell, Jeanette (Central Manchester University Hospitals NHS Foundation Trust) ; Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ; Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ; James, Paul (The Royal Melbourne Hospital) ; Mascarenhas, Lyon (Peter MacCallum Cancer Centre) ; McKinley, Joanne (Peter MacCallum Cancer Centre) ; Side, Lucy (Princess Anne Hospital) ; Thomas, Tessy (Princess Anne Hospital) ; van Asperen, Christi (Leiden University Medical Center) ; Vasen, Hans (The Foundation for the Detection of Hereditary Cancer) ; Kiemeney, Lambertus A. (Radboud University Medical Center) ; Ringelberg, Janneke (The Foundation for the Detection of Hereditary Cancer) ; Jensen, Thomas Dyrso. (Vejle Hospital) ; Osther, Palle J.S. (Vejle Hospital) ; Helfand, Brian T. (NorthShore University HealthSystem) ; Genova, Elena (NorthShore University HealthSystem) ; Oldenburg, Rogier A. (Erasmus University Medical Center) ; Cybulski, Cezary (Pomeranian Medical University in Szczecin) ; Wokolorczyk, Dominika (Pomeranian Medical University in Szczecin) ; Ong, Kai-Ren (Birmingham Women's Hospital) ; Huber, Camilla (Birmingham Women's Hospital) ; Lam, Jimmy (Bedford Park) ; Taylor, Louise (Daw Park) ; Salinas, Monica (Hospital Universitari de Bellvitge) ; Feliubadaló, Lidia (Hospital Universitari de Bellvitge) ; Oosterwijk, Jan C. (University of Groningen) ; van Zelst-Stams, Wendy (Radboud University Medical Center) ; Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ; Rosario, Derek J. (Royal Hallamshire Hospital) ; Domchek, Susan (Basser Research Center. University of Pennsylvania) ; Powers, Jacquelyn (University of Pennsylvania) ; Buys, Saundra (University of Utah) ; O'Toole, Karen (University of Utah) ; Ausems, Margreet G. E. M (University Medical Centre) ; Schmutzler, Rita K. (University Hospital Cologne) ; Rhiem, Kerstin (University Hospital Cologne) ; Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust) ; Tripathi, Vishakha (Guy's and St Thomas' NHS Foundation Trust) ; Teixeira, Manuel R. (Porto University) ; Cardoso, Marta (Portuguese Oncology Institute (IPO Porto)) ; Foulkes, William D. (McGill University) ; Aprikian, Armen (Research Institute of McGill University Health Centre) ; van Randeraad, Heleen (The Foundation for the Detection of Hereditary Cancer) ; Davidson, Rosemarie (Queen Elizabeth University Hospital) ; Longmuir, Mark (Queen Elizabeth University Hospital) ; Ruijs, Marielle W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Helderman van den Enden, Apollonia T.J.M. (Maastricht University Medical Center) ; Adank, Muriel (Amsterdam UMC) ; Williams, Rachel (Prince of Wales Hospital (Australia)) ; Andrews, Lesley (Prince of Wales Hospital (Australia)) ; Murphy, Declan G. (Peter MacCallum Cancer Centre) ; Halliday, Dorothy (Oxford Centre for Genomic Medicine) ; Walker, Lisa (Oxford Centre for Genomic Medicine) ; Liljegren, Annelie (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Carlsson, Stefan (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Azzabi, Ashraf (Newcastle upon Tyne Hospitals) ; Jobson, Irene (Newcastle upon Tyne Hospitals) ; Morton, Catherine (The Royal Melbourne Hospital) ; Shackleton, Kylie (The Royal Melbourne Hospital) ; Snape, Katie (St George's Hospital) ; Hanson, Helen (St George's Hospital) ; Harris, Marion (Monash Health) ; Tischkowitz, Marc (University of Cambridge) ; Taylor, Amy (Cambridge University Hospitals NHS Trust) ; Kirk, Judy (Sydney Medical School) ; Susman, Rachel (Royal Brisbane & Women's Hospital) ; Chen-Shtoyerman, Rakefet (Kaplan Medical Center) ; Spigelman, Allan (The Kinghorn Cancer Centre. St Vincent's Hospital) ; Pachter, Nicholas (University of Western Australia) ; Ahmed, Munaza (NE Thames Regional Genetics Service) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Zgajnar, Janez (Institute of Oncology) ; Brewer, Carole (Royal Devon and Exeter Hospital) ; Gadea, Neus (Hospital Universitari Vall d'Hebron) ; Brady, Angela F. (London North West University Healthcare NHS Trust) ; van Os, Theo (Academic Medical Center) ; Gallagher, David (St James's Hospital) ; Johannsson, Oskar (Landspitali University Hospital (Reykjavík, Islàndia)) ; Donaldson, Alan (St Michael's Hospital) ; Barwell, Julian (University Hospitals Leicester) ; Nicolai, Nicola (Istituto Nazionale dei Tumori) ; Friedman, Eitan (Chaim Shema Medical Center) ; Obeid, Elias (Fox Chase Cancer Center) ; Greenhalgh, Lynn (Liverpool Women's Hospital) ; Murthy, Vedana (Tata Memorial Centre) ; Copakova, Lucia (National Cancer Institute) ; Saya, Sibel (Institute of Cancer Research) ; McGrath, John (University of Exeter Medical School) ; Cooke, Peter (New Cross Hospital) ; Rønlund, Karina (Vejle Hospital) ; Richardson, Kate (Peter MacCallum Cancer Centre) ; Henderson, Alex (West Cumberland Infirmary) ; Teo, Soo H. (Subang Jaya Medical Centre) ; Arun, Banu (The University of Texas) ; Kast, Karin (Technische Universität Dresden) ; Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva (INCA)) ; Aaronson, Neil K (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust) ; Bangma, Chris H. (Erasmus University Medical Center) ; Castro, Elena (Spanish National Cancer Research Center) ; Dearnaley, David (The Institute of Cancer Research. Royal Marsden NHS Foundation Trust (Londres, Regne Unit)) ; Eccles, Diana M. (The University of Southampton Medical School) ; Tricker, Karen (Central Manchester University Hospitals NHS Foundation Trust) ; Eyfjord, Jorunn (University of Iceland) ; Falconer, Alison (Imperial College Healthcare NHS Trust) ; Foster, Christopher (HCA Pathology Laboratories) ; Gronberg, Henrik (University Hospital) ; Hamdy, Freddie C. (University of Oxford) ; Stefansdottir, Vigdis (Landspitali University Hospital (Reykjavík, Islàndia)) ; Khoo, Vincent (The University of Melbourne) ; Lindeman, Geoffrey J. (The Walter and Eliza Hall Institute of Medical Research) ; Lubinski, Jan (Pomeranian Medical University in Szczecin) ; Axcrona, Karol (Akershus University Hospital) ; Mikropoulos, Christos (Medway Hospital) ; Mitra, Anita (University College London Hospitals NHS Foundation Trust) ; Moynihan, Clare (Institute of Cancer Research) ; Rennert, Gadi (Carmel Medical Center) ; Suri, Mohnish (Nottingham City Hospital) ; Wilson, Penny (Innovate UK. Polaris House) ; Dudderidge, Tim (University Hospital Southampton) ; Offman, Judith (King's College London) ; Kote-Jarai, Zsofia (Institute of Cancer Research) ; Vickers, Andrew (Memorial Sloan Kettering Cancer Center) ; Lilja, Hans (Memorial Sloan-Kettering Cancer Center (Nova York, Estats Units d'Amèrica)) ; Eeles, Rosalind A. (Royal Marsden NHS Foundation Trust) ; Universitat Autònoma de Barcelona
Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluating targeted PrCa screening using prostate-specific-antigen (PSA) in men with germline BRCA1/2 mutations. [...]
2019 - 10.1016/j.eururo.2019.08.019
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 831-842  

Articles : 5,464 registres trobats   inicianterior433 - 442següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.